104 related articles for article (PubMed ID: 28823336)
41. Prognostic Value of the Hemoglobin/Red Cell Distribution Width Ratio in Resected Lung Adenocarcinoma.
Petrella F; Casiraghi M; Radice D; Cara A; Maffeis G; Prisciandaro E; Rizzo S; Spaggiari L
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33572378
[TBL] [Abstract][Full Text] [Related]
42. Salvage surgery after definitive chemoradiotherapy for patients with non-small cell lung cancer.
Hamada A; Soh J; Mitsudomi T
Transl Lung Cancer Res; 2021 Jan; 10(1):555-562. PubMed ID: 33569336
[TBL] [Abstract][Full Text] [Related]
43. Diagnosis and Treatment of Primary and Secondary Lung Cancers.
Petrella F
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33503954
[TBL] [Abstract][Full Text] [Related]
44. The Impact of Multidisciplinary Team Meetings on Patient Management in Oncologic Thoracic Surgery: A Single-Center Experience.
Petrella F; Radice D; Guarize J; Piperno G; Rampinelli C; de Marinis F; Spaggiari L
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33435181
[TBL] [Abstract][Full Text] [Related]
45. Pattern-of-failure and salvage treatment analysis after chemoradiotherapy for inoperable stage III non-small cell lung cancer.
Taugner J; Eze C; Käsmann L; Roengvoraphoj O; Gennen K; Karin M; Petrukhnov O; Tufman A; Belka C; Manapov F
Radiat Oncol; 2020 Jun; 15(1):148. PubMed ID: 32517716
[TBL] [Abstract][Full Text] [Related]
46. Application of radiography of computed tomography in non-small cell lung cancer using prognosis model.
Jin Y; Lu T
Saudi J Biol Sci; 2020 Apr; 27(4):1066-1072. PubMed ID: 32256167
[TBL] [Abstract][Full Text] [Related]
47. Salvage surgery for advanced non-small cell lung cancer after targeted therapy: A case series.
Song W; Di S; Liu J; Fan B; Zhao J; Zhou S; Chen S; Dong H; Yue C; Gong T
Thorac Cancer; 2020 Apr; 11(4):1061-1067. PubMed ID: 32107870
[TBL] [Abstract][Full Text] [Related]
48. Erastin/sorafenib induces cisplatin-resistant non-small cell lung cancer cell ferroptosis through inhibition of the Nrf2/xCT pathway.
Li Y; Yan H; Xu X; Liu H; Wu C; Zhao L
Oncol Lett; 2020 Jan; 19(1):323-333. PubMed ID: 31897145
[TBL] [Abstract][Full Text] [Related]
49. Impact of histology on patterns of failure and clinical outcomes in patients treated with definitive chemoradiotherapy for locally advanced non-small cell lung cancer.
Ito H; Matsuo Y; Ohtsu S; Nishimura T; Terada Y; Sakamoto T; Mizowaki T
Int J Clin Oncol; 2020 Feb; 25(2):274-281. PubMed ID: 31667664
[TBL] [Abstract][Full Text] [Related]
50. Surgery for stage IIIA-N2 non-small cell lung cancer: the jury is still out!
Berzenji L; Beckers P; Van Schil PE
J Thorac Dis; 2019 May; 11(Suppl 9):S1153-S1156. PubMed ID: 31245070
[No Abstract] [Full Text] [Related]
51. Trimodality vs Chemoradiation and Salvage Resection in cN2 Stage IIIA Non-Small Cell Lung Cancer.
Ye JC; Ding L; Atay SM; Nieva JJ; McFadden PM; Chang E; Kim AW
Semin Thorac Cardiovasc Surg; 2020; 32(1):153-159. PubMed ID: 31220530
[TBL] [Abstract][Full Text] [Related]
52. Salvage surgery for recurrent or persistent tumour after radical (chemo)radiotherapy for locally advanced non-small cell lung cancer: a systematic review.
Dickhoff C; Otten RHJ; Heymans MW; Dahele M
Ther Adv Med Oncol; 2018; 10():1758835918804150. PubMed ID: 30305851
[TBL] [Abstract][Full Text] [Related]
53. Feasibility and efficacy of salvage lung resection after definitive chemoradiation therapy for Stage III non-small-cell lung cancer.
Shimada Y; Suzuki K; Okada M; Nakayama H; Ito H; Mitsudomi T; Saji H; Takamochi K; Kudo Y; Hattori A; Mimae T; Aokage K; Nishii T; Tsuboi M; Ikeda N
Interact Cardiovasc Thorac Surg; 2016 Dec; 23(6):895-901. PubMed ID: 27543652
[TBL] [Abstract][Full Text] [Related]
54. Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer?
Schreiner W; Dudek W; Lettmaier S; Fietkau R; Sirbu H
J Cardiothorac Surg; 2016 Jan; 11():9. PubMed ID: 26781697
[TBL] [Abstract][Full Text] [Related]
55. Is salvage surgery for recurrent non-small-cell lung cancer after definitive non-operative therapy associated with reasonable survival?
Schreiner W; Dudek W; Sirbu H
Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):682-4. PubMed ID: 26323288
[TBL] [Abstract][Full Text] [Related]
56. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
[TBL] [Abstract][Full Text] [Related]
57. Salvage Surgery After Definitive Chemoradiotherapy for Non-small Cell Lung Cancer.
Casiraghi M; Maisonneuve P; Piperno G; Bellini R; Brambilla D; Petrella F; Marinis F; Spaggiari L
Semin Thorac Cardiovasc Surg; 2017 Summer; 29(2):233-241. PubMed ID: 28823336
[TBL] [Abstract][Full Text] [Related]
58. Long-Term Survival after Salvage Surgery for Local Failure after Definitive Chemoradiation Therapy for Locally Advanced Non-small Cell Lung Cancer.
Schreiner W; Dudek W; Lettmaier S; Fietkau R; Sirbu H
Thorac Cardiovasc Surg; 2018 Mar; 66(2):135-141. PubMed ID: 28992654
[TBL] [Abstract][Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
